Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 1 Months Ended 11 Months Ended 12 Months Ended
Jun. 07, 2013
Dec. 29, 2013
Apr. 28, 2013
Apr. 29, 2012
Apr. 27, 2011
Investing Activities:          
Acquisitions, net of cash acquired         $ (618,302)
Financing Activities:          
Exercise of stock options 900   113,500 82,700 154,800
Earn-out settlement   (44,547)      
Successor [Member]
          
Operating Activities:          
Loss from continuing operations   (71,718)      
Adjustments to reconcile net income to cash provided by operating activities:          
Depreciation   230,987      
Amortization   48,975      
Amortization of deferred debt issuance costs   29,091      
Inventory fair value step-up charged to cost of products sold   383,300      
Deferred tax (benefit)/provision   (298,003)      
Net losses on divestitures   0      
Impairment on assets held for sale   0      
Pension contributions   (152,116)      
Asset write-downs from Fiscal 2012 productivity initiatives   0      
Unrealized gain on derivative instruments   (117,934)      
Other items, net   49,535      
Changes in current assets and liabilities, excluding effects of acquisitions and divestitures:          
Receivables (includes proceeds from securitization)   (118,509)      
Inventories   84,339      
Prepaid expenses and other current assets   43,630      
Accounts payable   (89,807)      
Accrued liabilities   77,724      
Income taxes   (64,436)      
Cash provided by operating activities   35,058      
Investing Activities:          
Capital expenditures   (202,015)      
Proceeds from disposals of property, plant and equipment   6,098      
Acquisitions, net of cash acquired   (21,494,287)      
Proceeds from divestitures   25,987      
Sale of short-term investments   0      
Change in restricted cash   0      
Other items, net   (7,214)      
Cash used for investing activities   (21,671,431)      
Financing Activities:          
Payments on long-term debt   (2,669,915)      
Proceeds from long-term debt   12,574,575      
Debt issuance costs   (320,824)      
Net proceds/(payments) on commercial paper and short-term debt   (1,640,590)      
Dividends   (360,000)      
Purchase of treasury stock   0      
Exercise of stock options   0      
Acquisition of subsidiary shares from noncontrolling interests   0      
Capital contributions   16,500,000      
Other items, net   25,995      
Cash provided by/(used for) financing activities   24,109,241      
Effect of exchange rate changes on cash and cash equivalents   (13,876)      
Net increase in cash and cash equivalents   2,458,992      
Cash and cash equivalents at beginning of year   0      
Cash and cash equivalents at end of year   2,458,992      
Predecessor [Member]
          
Operating Activities:          
Loss from continuing operations (192,697)   1,027,333 939,908 1,005,948
Adjustments to reconcile net income to cash provided by operating activities:          
Depreciation 35,880   302,057 295,718 255,227
Amortization 4,276   42,161 43,499 39,597
Amortization of deferred debt issuance costs 867   4,692 3,576 3,836
Inventory fair value step-up charged to cost of products sold 0   0 0 0
Deferred tax (benefit)/provision (20,492)   (87,265) (94,816) 153,725
Net losses on divestitures 0   19,532 0 0
Impairment on assets held for sale 0   36,000 0 0
Pension contributions (6,812)   (69,388) (23,469) (22,411)
Asset write-downs from Fiscal 2012 productivity initiatives 0   0 58,736 0
Unrealized gain on derivative instruments 0   0 0 0
Other items, net 23,706   84,834 75,375 98,172
Changes in current assets and liabilities, excluding effects of acquisitions and divestitures:          
Receivables (includes proceeds from securitization) (3,360)   (166,239) 171,832 (91,057)
Inventories (183,413)   (49,468) 60,919 (80,841)
Prepaid expenses and other current assets (18,411)   14,111 (11,584) (1,682)
Accounts payable (69,825)   168,898 (72,352) 233,339
Accrued liabilities 48,025   71,846 (20,008) (60,862)
Income taxes 10,163   (9,141) 65,783 50,652
Cash provided by operating activities (372,093)   1,389,963 1,493,117 1,583,643
Investing Activities:          
Capital expenditures (120,154)   (399,098) (418,734) (335,646)
Proceeds from disposals of property, plant and equipment 108   18,986 9,817 13,158
Acquisitions, net of cash acquired 0   0 (3,250) (618,302)
Proceeds from divestitures 0   16,787 3,828 1,939
Sale of short-term investments     0 56,780 0
Change in restricted cash 33,892   3,994 (39,052) (5,000)
Other items, net (3,641)   (13,789) (11,394) (5,781)
Cash used for investing activities (89,795)   (373,120) (402,005) (949,632)
Financing Activities:          
Payments on long-term debt (439,747)   (224,079) (1,440,962) (45,766)
Proceeds from long-term debt 1,521   205,350 1,912,467 229,851
Debt issuance costs 0   0 0 0
Net proceds/(payments) on commercial paper and short-term debt 480,672   1,089,882 (42,543) (193,200)
Dividends 0   (665,691) (619,104) (579,618)
Purchase of treasury stock 0   (139,069) (201,904) (70,003)
Exercise of stock options 886   113,477 82,714 154,774
Acquisition of subsidiary shares from noncontrolling interests 0   (80,132) (54,824) (6,338)
Capital contributions 0   0 0 0
Other items, net 42,086   (42,811) 1,321 27,791
Cash provided by/(used for) financing activities 85,418   256,927 (362,835) (482,509)
Effect of exchange rate changes on cash and cash equivalents (30,262)   (127,512) (122,147) 89,556
Net increase in cash and cash equivalents (406,732)   1,146,258 606,130 241,058
Cash and cash equivalents at beginning of year 2,476,699   1,330,441 724,311 483,253
Cash and cash equivalents at end of year $ 2,069,967   $ 2,476,699 $ 1,330,441 $ 724,311